One Article, Thirty Years
Alpha lipoic acid, the antioxidant supplement, taken by the Investigator, LR, sixty-two, every day for something close to thirty years on the strength of a single article she read in the late nineteen-nineties. The article said the supplement stops the body oxidizing from the inside out. The question is whether three decades of faithful use is evidence that it worked, or evidence of something else worth naming.
That a daily alpha lipoic acid supplement slows the oxidative wear of aging in a healthy person, and that a long life of taking it is proof that it did.
LR has taken alpha lipoic acid daily for roughly twenty-five to thirty years, and her account of why she started and never stopped is the primary evidence. Felix then read the supplement literature, the clinical trials, and the large antioxidant reviews to weigh what that habit can and cannot show. The references were read on 6 September 2026 and the verdict locked the same day. LR's exact dose across the decades is not recorded here, and where the science turns on dose, the clinical figure of six hundred milligrams is named.
The evidence is real in one narrow place and thin in the one LR bought it for. Alpha lipoic acid has genuine, repeated trial support for diabetic nerve pain at a clinical dose. The wider promise, that an antioxidant supplement slows aging in a healthy body, is the promise the largest reviews tested and did not confirm.
LR read one article, made one decision, and kept it for thirty years, and at sixty-two she is well. That is a real life and a real habit. It is not, on its own, a measurement.
A single article, and a thirty-year habit
Most supplements are a phase. A person reads something, buys a bottle, finishes half of it, and moves on to the next promise. Alpha lipoic acid was not a phase for the Investigator. She read one article in the late nineteen-nineties, the kind that said the supplement stops the body oxidizing from the inside out, and she started taking it. She is still taking it. Somewhere between twenty-five and thirty years have passed, and at sixty-two she is well and happy to say so. This bulletin owes that habit two things at once, respect and honesty, and it intends to pay both.
A word on method, because the value of a verdict is the honesty of the work under it. LR’s account is the primary evidence, and the science that follows exists to weigh it rather than to flatter it. The supplement literature and the clinical trials were read on 6 September 2026. The four kinds of sentence are kept apart on purpose, as ever: LR observed this, research has demonstrated this, the wider trials have failed to confirm this, and the article that started it all claimed this.
What the Investigator found
These are LR’s own words, and the rest of this bulletin exists to weigh them fairly.
I read an article about twenty-five years ago that said alpha lipoic acid stops you oxidizing from the inside out. That was the whole of it. It made sense to me, so I started taking it, and I did not stop. It has been thirty years, or maybe twenty-five, and I have not made a decision about it since the first one. I am sixty-two. I am well. I cannot tell you it is the reason, and I am not going to pretend I ran an experiment, because I did not. I took a pill every day for most of my adult life on the strength of one good sentence, and here I am. Make of that what you will, and I will keep taking it while you decide.
Testimony first. The science comes second, and its job is to say what that testimony can carry and what it cannot.
What alpha lipoic acid actually is
The article LR read was not selling nonsense, which is the first thing an honest bulletin has to admit. Alpha lipoic acid is a real antioxidant, and an unusually capable one. A 2009 review by Shay and colleagues in Biochimica et Biophysica Acta, the standard reference on the compound, describes it as a molecule that scavenges free radicals, chelates loose metals, and restores the body’s own master antioxidant, glutathione, which otherwise falls with age. It dissolves in both water and fat, so it reaches places that single-solubility antioxidants cannot, and it works as a cofactor deep in the machinery that turns food into energy. The premise that it fights oxidation inside the body is not a marketing invention. It is chemistry, and the chemistry is sound.
The same review names the catch that every honest account has to set next to the promise. Taken as a pill, alpha lipoic acid has an oral availability of only about thirty percent, and it clears the body fast, with a half-life near thirty minutes. A once-daily capsule is a brief visitor to the bloodstream, present for a short window and then gone. Whatever it does, it does in flashes rather than as a steady tide.
Where the evidence is strong
Alpha lipoic acid has one lane where the evidence is genuinely strong, and it is worth knowing precisely, because precision is the difference between a supplement that works and a supplement that works for you. The lane is diabetic nerve pain. A 2012 meta-analysis by Han and colleagues, pooling randomized trials that reach back to the German ALADIN study of the mid-nineteen-nineties, found that alpha lipoic acid at six hundred milligrams produced a real, measurable reduction in the burning and tingling of diabetic peripheral neuropathy. Research has demonstrated this. A person with that condition has a sound, evidence-backed reason to take it, at that dose, and many doctors prescribe it for exactly this.
Notice what that finding is, and what it is not. It is proof that the molecule does something real in a specific injured system at a specific dose. It is not proof that the same molecule slows the ordinary aging of a healthy body, which is a different claim in a different population, and it is the claim LR actually bought.
Where the promise thins
The promise LR acted on, that an antioxidant taken daily holds off the wear of aging from the inside, is one of the most tested ideas in modern medicine, and the testing did not go the way the article implied. When researchers gathered the antioxidant-supplement trials together, the result was sobering. A 2012 Cochrane review by Bjelakovic and colleagues pooled seventy-eight randomized trials covering nearly three hundred thousand people, and it found that antioxidant supplements did not lower the risk of death. Worse, some of them, beta-carotene and vitamin E in particular, appeared to raise it. Alpha lipoic acid was not the subject of those trials by name, so this is not a verdict on it alone. It is a verdict on the whole family of the idea, and it lands hard on the sentence that started LR’s habit.
The theory underneath the article, that aging is oxidation and that swallowing antioxidants slows it, is no longer the settled science it sounded like in the nineteen-nineties. The body runs its own antioxidant defenses, some oxidation is signal rather than damage, and flooding the system from outside has not delivered the long-life dividend it promised. The premise was reasonable. The returns did not arrive on the scale the promise implied.
What thirty years can and cannot show
That leaves the thirty years, which is the heart of this bulletin and the hardest part to grade, because it is the part everyone feels and no one can measure. LR is sixty-two and well, and she has taken this supplement for most of her adult life. The temptation is to draw a line from the pill to the health and call it proof. The line cannot honestly be drawn. A single person living a single life cannot separate one daily habit from her genes, her diet, her sleep, her luck, her doctors, and the thousand other things that carried her to sixty-two in good shape. She is the only subject, there is no version of her who skipped the pill to compare against, and thirty years of feeling fine is exactly what both a working supplement and a harmless one would produce. This is not a knock on LR. It is the reason careful people run trials instead of trusting the strongest anecdote in the room, even when the anecdote is their own.
There is a gentler truth sitting beside the hard one. A habit that a thoughtful woman kept for thirty years, that never harmed her and never bankrupted her, is not nothing. It is a small daily act of tending herself, chosen on a reasonable premise and held with a constancy most resolutions never reach. The Laboratory can decline to call that proof and still call it admirable, because both readings are honest, and only a fool would hand her the cold one on its own.
The four weights, kept apart
A review is worth nothing if it blurs the four kinds of true, so here they are held apart.
LR observed thirty years of daily use and a life that arrived at sixty-two in good health. That is testimony, it is hers, and it is not in question.
Research has demonstrated that alpha lipoic acid relieves diabetic nerve pain at six hundred milligrams. That is a real clinical fact about a specific condition at a specific dose.
The wider trials have failed to confirm that antioxidant supplements slow aging or extend life in healthy people, and some antioxidants raised the risk of death. That is the evidence that speaks most directly to why LR began.
The article claimed that the supplement stops the body oxidizing from the inside out. That is the weight with the least behind it for a healthy person, and it is the one that set a thirty-year habit in motion.
The finding
Approved, with conditions, and the conditions are unusually gentle, because the product is unusually safe.
Alpha lipoic acid is inexpensive, well tolerated by most people, and genuinely useful for at least one real condition. Taking it daily carries a long safety record, and LR is the living evidence that a person can keep the habit for decades without harm. If it belongs to her routine and her sense of tending herself, she should keep it, and this Laboratory is not in the business of talking a well woman out of a safe, cheap, considered habit.
The conditions are two, and they are about meaning rather than danger. The first is that the reason on the label is not the reason in the evidence. The strong proof is for diabetic nerve pain, not for slowing the aging of a healthy body, and the grand antioxidant promise is the one the largest reviews declined to confirm. A reader should take it clear-eyed about which of those she is buying. The second is a small matter of safety worth stating plainly. Alpha lipoic acid can lower blood sugar, and rare cases of dangerously low blood sugar have been reported, so anyone on diabetes medication or prone to hypoglycemia should raise it with a doctor before starting. Beyond that, the risk is low and the habit is defensible.
What LR has, in the end, is thirty years of a safe, cheap, reasonable choice and a life she is glad to be living inside. The pill may have helped at the margins, and it certainly did not hurt. The rest is hers, and the Laboratory would not dream of taking it from her.
References
Sourcing note: the supplement literature and clinical trials below were read on 6 September 2026, and the verdict was locked the same day. LR’s exact dose and brand across the decades are not recorded in this bulletin, and where the science turns on dose, the clinical figure of six hundred milligrams is named. None of the references is linked to a store, because a Bulletin never sells.
- Shay et al., Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential, Biochimica et Biophysica Acta, 2009.
pubmed.ncbi.nlm.nih.gov/19664690/ - Han et al., Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials, 2012.
pubmed.ncbi.nlm.nih.gov/22331979/ - Ziegler et al., Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid, the ALADIN study, Diabetologia, 1995.
pubmed.ncbi.nlm.nih.gov/8786016/ - Bjelakovic et al., Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases, Cochrane Database of Systematic Reviews, 2012.
pubmed.ncbi.nlm.nih.gov/22419320/
Approved with conditions
The finding is honest, which is the only reason the recommendation beneath it is believed. A verdict may conclude that the right answer is to want nothing.